Mineralys Therapeutics (MLYS) Cash & Equivalents (2022 - 2026)
Quarterly results put Cash & Equivalents at $111.6 million for Q1 2026, down 32.35% from a year ago — trailing twelve months through Mar 2026 was $111.6 million (down 32.35% YoY), and the annual figure for FY2025 was $171.9 million, up 50.66%.
Mineralys Therapeutics has reported Cash & Equivalents over the past 5 years, most recently at $111.6 million for Q1 2026.
- Cash & Equivalents reached $111.6 million in Q1 2026 per MLYS's latest filing, down from $171.9 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $216.4 million in Q3 2025 and bottomed at $49.3 million in Q4 2023.
- Median Cash & Equivalents over the past 5 years was $101.0 million (2023), compared with a mean of $113.6 million.
- The largest annual shift saw Cash & Equivalents crashed 41.88% in 2023 before it skyrocketed 131.4% in 2024.
- Over 5 years, Cash & Equivalents stood at $84.8 million in 2022, then plummeted by 41.88% to $49.3 million in 2023, then surged by 131.4% to $114.1 million in 2024, then surged by 50.66% to $171.9 million in 2025, then plummeted by 35.06% to $111.6 million in 2026.
- Business Quant data shows Cash & Equivalents for MLYS at $111.6 million in Q1 2026, $171.9 million in Q4 2025, and $216.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 1.91 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 32.30 Mn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 901.90 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 61.46 Mn |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 2.77 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 5.49 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 2.96 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 18.44 Mn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 1.71 Bn |
| 10 | Mineralys Therapeutics | 2.50 Bn | 2.50 Bn | - | 111.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 111.63 Mn |
| Dec 31, 2025 | 171.89 Mn |
| Sep 30, 2025 | 216.38 Mn |
| Jun 30, 2025 | 100.78 Mn |
| Mar 31, 2025 | 165.01 Mn |
| Dec 31, 2024 | 114.09 Mn |
| Sep 30, 2024 | 97.27 Mn |
| Jun 30, 2024 | 67.86 Mn |
| Mar 31, 2024 | 85.04 Mn |
| Dec 31, 2023 | 49.30 Mn |
| Sep 30, 2023 | 86.30 Mn |
| Jun 30, 2023 | 101.14 Mn |
| Mar 31, 2023 | 138.25 Mn |
| Dec 31, 2022 | 84.83 Mn |